In focus · trending topic

combination therapy

3 stories · following the connections

India Globalization Capital’s CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 13

By Nasdaq OMXFeb 12, 2018, 1:02 PM UTC

Peregrine Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial Evaluating Bavituximab Treatment Combination in Patients with Newly Diagnosed Glioblastoma

By Nasdaq OMXSep 7, 2017, 12:10 PM UTC

IGC Provides Update on Phytocannabinoid IP Portfolio

By Nasdaq OMXNov 2, 2016, 1:32 PM UTC